Moderna, Inc. (MRNA) Operating margin 2016–2025
Moderna, Inc. (MRNA) operating margin by fiscal year — reported operating income divided by reported revenue.
-158.1%FY2025 · since FY2016: -206.4% → -158.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -158.1% | -36.2 pp |
| FY2024 | -121.9% | -60.0 pp |
| FY2023 | -61.9% | -110.8 pp |
| FY2022 | 48.9% | -23.1 pp |
| FY2021 | 72.0% | +167.0 pp |
| FY2020 | -95.0% | +811.8 pp |
| FY2019 | -906.8% | -600.9 pp |
| FY2018 | -306.0% | -175.1 pp |
| FY2017 | -130.9% | +75.6 pp |
| FY2016 | -206.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More MRNA financial trends
MRNA RevenueMRNA Net incomeMRNA Net marginMRNA Gross profitMRNA Gross marginMRNA Operating incomeMRNA Operating cash flowMRNA Free cash flowMRNA Capital expendituresMRNA Return on equityMRNA Stock buybacksMRNA Dividends paidMRNA Total assetsMRNA Total liabilitiesMRNA Shareholders’ equityMRNA overview →